Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
George Macones is an Obstetrics and Gynecologist and a Neonatologist in Saint Louis, Missouri. Macones has been practicing medicine for over 24 years and is rated as an Elite expert by MediFind in the treatment of Small for Gestational Age. He is also highly rated in 18 other conditions, according to our data. His top areas of expertise are Macrosomia, Intrauterine Growth Restriction, Small for Gestational Age, Hysterectomy, and Salpingo-Oophorectomy. He is licensed to treat patients in Missouri. Macones is currently accepting new patients.
Alison Cahill is an Obstetrics and Gynecologist and a Neonatologist in Austin, Texas. Cahill has been practicing medicine for over 21 years and is rated as an Elite expert by MediFind in the treatment of Small for Gestational Age. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Macrosomia, Intrauterine Growth Restriction, Small for Gestational Age, Angioplasty, and Hysterectomy. She is licensed to treat patients in Missouri. Cahill is currently accepting new patients.
Anthony Odibo is an Obstetrics and Gynecologist and a Neonatologist in Tampa, Florida. Odibo has been practicing medicine for over 37 years and is rated as an Elite expert by MediFind in the treatment of Small for Gestational Age. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Small for Gestational Age, Intrauterine Growth Restriction, Preeclampsia, Macrosomia, and Hysterectomy. He is licensed to treat patients in Missouri. Odibo is currently accepting new patients.
Objectives: Primary Objectives: -To describe the safety of PfSPZ Vaccine at 9x105 PfSPZ at dosing schedule of 1, 8, 29 days in pregnant women and their fetuses using a composite measure of adverse maternal and birth outcomes Secondary Objectives: To describe the safety and tolerability of PfSPZ Vaccine at 9x10^5 PfSPZ at dosing schedule of 1, 8, 29 days in pregnant women and their fetuses using solicited adve...
Summary: This is a prospective, observational, exposure cohort study of pregnancy and infant outcomes in women with asthma exposed to benralizumab anytime during pregnancy, or within 8 weeks prior to the first day of the last menstrual period (LMP) The objective of the study is to monitor planned or unplanned pregnancies to evaluate potential teratogenic effect (birth defect) when exposed to benralizumab c...